Biological
CM512 clinical trials
- studies test it
- 10
- open now
- 8
- in phase 3
- 1
- first study started
- 2024
Keep track of what changes. Save the CM512 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
10 studies that test it; most in 2025 (6)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 8
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Keymed Biosciences Co.Ltd (7) · Beijing Keymed Biosciences Co., Ltd. (3)
Studies
Open first, then newest update. How each study uses CM512 is read from its arms, and is right about nine times in ten.
Testing it · 10
- Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background TherapyNot yet recruitingPhase 2Beijing Keymed Biosciences Co., Ltd.NCT07890350Written as CM512
- A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-3)Not yet recruitingPhase 3Beijing Keymed Biosciences Co., Ltd.NCT07807826Written as CM512
- A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-2)Not yet recruitingPhase 2Keymed Biosciences Co.LtdNCT07519577Written as CM512
- Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)RecruitingPhase 2Keymed Biosciences Co.LtdNCT07166211Written as CM512 injection
- A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.RecruitingPhase 2Keymed Biosciences Co.LtdNCT07230483Written as CM512
- Study of CM512 Injection in Subjects With Moderate-to-severe AsthmaRecruitingPhase 2Keymed Biosciences Co.LtdNCT07011524Written as CM512 injection
- Study of CM512 in Patients With Moderate-to-Severe Atopic DermatitisRecruitingPhase 2Keymed Biosciences Co.LtdNCT06947980Written as CM512
- A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingPhase 2Keymed Biosciences Co.LtdNCT06980142Written as CM512
- A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-1)CompletedPhase 2Beijing Keymed Biosciences Co., Ltd.NCT06930612Written as CM512
- Study of CM512 in Healthy Subjects and Patients With Atopic DermatitisCompletedPhase 1Keymed Biosciences Co.LtdNCT06553209Written as CM512